Reprogramming of skeletal myoblasts for induction of pluripotency for tumor-free cardiomyogenesis in the infarcted heart

Rafeeq P.H. Ahmed, Husnain K. Haider, Stephanie Buccini, Longhu Li, Shujia Jiang, Muhammad Ashraf

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Rationale: Skeletal myoblasts (SMs) with inherent myogenic properties are better candidates for reprogramming to pluripotency. Objective: To reprogram SMs to pluripotency and show that reprogrammed SMs (SiPS) express embryonic gene and microRNA profiles and that transplantation of predifferentiated cardiac progenitors reduce tumor formation. Methods and Results: The pMXs vector containing mouse cDNAs for Yamanaka's quartet of stemness factors were used for transduction of SMs purified from male Oct4-GFP transgenic mouse. Three weeks later, GFP colonies of SiPS were isolated and propagated in vitro. SiPS were positive for alkaline phosphatase, expressed SSEA1, and displayed a panel of embryonic stem (ES) cell-specific pluripotency markers. Embryoid body formation yielded beating cardiomyocyte-like cells, which expressed early and late cardiac-specific markers. SiPS also had an microRNA profile that was altered during their cardiomyogenic differentiation. Noticeable abrogation of let-7 family and significant up-regulation of miR-200a-c was observed in SiPS and SiPS-derived cardiomyocytes, respectively. In vivo studies in an experimental model of acute myocardial infarction showed extensive survival of SiPS and SiPS-derived cardiomyocytes in mouse heart after transplantation. Our results from 4-week studies in DMEM without cells (group 1), SMs (group-2), SiPS (group-3), and SiPS-derived cardiomyocytes (group 4) showed extensive myogenic integration of the transplanted cells in group 4 with attenuated infarct size and improved cardiac function without tumorgenesis. Conclusions: Successful reprogramming was achieved in SMs with ES cell-like microRNA profile. Given the tumorgenic nature of SiPS, their predifferentiation into cardiomyocytes would be important for tumor-free cardiogenesis in the heart.

Original languageEnglish (US)
Pages (from-to)60-70
Number of pages11
JournalCirculation research
Volume109
Issue number1
DOIs
StatePublished - Jun 24 2011

Fingerprint

Skeletal Myoblasts
Cardiac Myocytes
MicroRNAs
Neoplasms
Heart Transplantation
Embryonic Stem Cells
Embryoid Bodies
Transgenic Mice
Alkaline Phosphatase
Theoretical Models
Up-Regulation
Complementary DNA
Myocardial Infarction
Genes

Keywords

  • heart
  • iPS cells
  • infarction
  • pluripotent
  • predifferentiation
  • reprogramming
  • tumor formation

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Reprogramming of skeletal myoblasts for induction of pluripotency for tumor-free cardiomyogenesis in the infarcted heart. / Ahmed, Rafeeq P.H.; Haider, Husnain K.; Buccini, Stephanie; Li, Longhu; Jiang, Shujia; Ashraf, Muhammad.

In: Circulation research, Vol. 109, No. 1, 24.06.2011, p. 60-70.

Research output: Contribution to journalArticle

Ahmed, Rafeeq P.H. ; Haider, Husnain K. ; Buccini, Stephanie ; Li, Longhu ; Jiang, Shujia ; Ashraf, Muhammad. / Reprogramming of skeletal myoblasts for induction of pluripotency for tumor-free cardiomyogenesis in the infarcted heart. In: Circulation research. 2011 ; Vol. 109, No. 1. pp. 60-70.
@article{76e987ed77634fd7b3e18fa9bea35fb5,
title = "Reprogramming of skeletal myoblasts for induction of pluripotency for tumor-free cardiomyogenesis in the infarcted heart",
abstract = "Rationale: Skeletal myoblasts (SMs) with inherent myogenic properties are better candidates for reprogramming to pluripotency. Objective: To reprogram SMs to pluripotency and show that reprogrammed SMs (SiPS) express embryonic gene and microRNA profiles and that transplantation of predifferentiated cardiac progenitors reduce tumor formation. Methods and Results: The pMXs vector containing mouse cDNAs for Yamanaka's quartet of stemness factors were used for transduction of SMs purified from male Oct4-GFP transgenic mouse. Three weeks later, GFP colonies of SiPS were isolated and propagated in vitro. SiPS were positive for alkaline phosphatase, expressed SSEA1, and displayed a panel of embryonic stem (ES) cell-specific pluripotency markers. Embryoid body formation yielded beating cardiomyocyte-like cells, which expressed early and late cardiac-specific markers. SiPS also had an microRNA profile that was altered during their cardiomyogenic differentiation. Noticeable abrogation of let-7 family and significant up-regulation of miR-200a-c was observed in SiPS and SiPS-derived cardiomyocytes, respectively. In vivo studies in an experimental model of acute myocardial infarction showed extensive survival of SiPS and SiPS-derived cardiomyocytes in mouse heart after transplantation. Our results from 4-week studies in DMEM without cells (group 1), SMs (group-2), SiPS (group-3), and SiPS-derived cardiomyocytes (group 4) showed extensive myogenic integration of the transplanted cells in group 4 with attenuated infarct size and improved cardiac function without tumorgenesis. Conclusions: Successful reprogramming was achieved in SMs with ES cell-like microRNA profile. Given the tumorgenic nature of SiPS, their predifferentiation into cardiomyocytes would be important for tumor-free cardiogenesis in the heart.",
keywords = "heart, iPS cells, infarction, pluripotent, predifferentiation, reprogramming, tumor formation",
author = "Ahmed, {Rafeeq P.H.} and Haider, {Husnain K.} and Stephanie Buccini and Longhu Li and Shujia Jiang and Muhammad Ashraf",
year = "2011",
month = "6",
day = "24",
doi = "10.1161/CIRCRESAHA.110.240010",
language = "English (US)",
volume = "109",
pages = "60--70",
journal = "Circulation Research",
issn = "0009-7330",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Reprogramming of skeletal myoblasts for induction of pluripotency for tumor-free cardiomyogenesis in the infarcted heart

AU - Ahmed, Rafeeq P.H.

AU - Haider, Husnain K.

AU - Buccini, Stephanie

AU - Li, Longhu

AU - Jiang, Shujia

AU - Ashraf, Muhammad

PY - 2011/6/24

Y1 - 2011/6/24

N2 - Rationale: Skeletal myoblasts (SMs) with inherent myogenic properties are better candidates for reprogramming to pluripotency. Objective: To reprogram SMs to pluripotency and show that reprogrammed SMs (SiPS) express embryonic gene and microRNA profiles and that transplantation of predifferentiated cardiac progenitors reduce tumor formation. Methods and Results: The pMXs vector containing mouse cDNAs for Yamanaka's quartet of stemness factors were used for transduction of SMs purified from male Oct4-GFP transgenic mouse. Three weeks later, GFP colonies of SiPS were isolated and propagated in vitro. SiPS were positive for alkaline phosphatase, expressed SSEA1, and displayed a panel of embryonic stem (ES) cell-specific pluripotency markers. Embryoid body formation yielded beating cardiomyocyte-like cells, which expressed early and late cardiac-specific markers. SiPS also had an microRNA profile that was altered during their cardiomyogenic differentiation. Noticeable abrogation of let-7 family and significant up-regulation of miR-200a-c was observed in SiPS and SiPS-derived cardiomyocytes, respectively. In vivo studies in an experimental model of acute myocardial infarction showed extensive survival of SiPS and SiPS-derived cardiomyocytes in mouse heart after transplantation. Our results from 4-week studies in DMEM without cells (group 1), SMs (group-2), SiPS (group-3), and SiPS-derived cardiomyocytes (group 4) showed extensive myogenic integration of the transplanted cells in group 4 with attenuated infarct size and improved cardiac function without tumorgenesis. Conclusions: Successful reprogramming was achieved in SMs with ES cell-like microRNA profile. Given the tumorgenic nature of SiPS, their predifferentiation into cardiomyocytes would be important for tumor-free cardiogenesis in the heart.

AB - Rationale: Skeletal myoblasts (SMs) with inherent myogenic properties are better candidates for reprogramming to pluripotency. Objective: To reprogram SMs to pluripotency and show that reprogrammed SMs (SiPS) express embryonic gene and microRNA profiles and that transplantation of predifferentiated cardiac progenitors reduce tumor formation. Methods and Results: The pMXs vector containing mouse cDNAs for Yamanaka's quartet of stemness factors were used for transduction of SMs purified from male Oct4-GFP transgenic mouse. Three weeks later, GFP colonies of SiPS were isolated and propagated in vitro. SiPS were positive for alkaline phosphatase, expressed SSEA1, and displayed a panel of embryonic stem (ES) cell-specific pluripotency markers. Embryoid body formation yielded beating cardiomyocyte-like cells, which expressed early and late cardiac-specific markers. SiPS also had an microRNA profile that was altered during their cardiomyogenic differentiation. Noticeable abrogation of let-7 family and significant up-regulation of miR-200a-c was observed in SiPS and SiPS-derived cardiomyocytes, respectively. In vivo studies in an experimental model of acute myocardial infarction showed extensive survival of SiPS and SiPS-derived cardiomyocytes in mouse heart after transplantation. Our results from 4-week studies in DMEM without cells (group 1), SMs (group-2), SiPS (group-3), and SiPS-derived cardiomyocytes (group 4) showed extensive myogenic integration of the transplanted cells in group 4 with attenuated infarct size and improved cardiac function without tumorgenesis. Conclusions: Successful reprogramming was achieved in SMs with ES cell-like microRNA profile. Given the tumorgenic nature of SiPS, their predifferentiation into cardiomyocytes would be important for tumor-free cardiogenesis in the heart.

KW - heart

KW - iPS cells

KW - infarction

KW - pluripotent

KW - predifferentiation

KW - reprogramming

KW - tumor formation

UR - http://www.scopus.com/inward/record.url?scp=79960011550&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960011550&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.110.240010

DO - 10.1161/CIRCRESAHA.110.240010

M3 - Article

C2 - 21566212

AN - SCOPUS:79960011550

VL - 109

SP - 60

EP - 70

JO - Circulation Research

JF - Circulation Research

SN - 0009-7330

IS - 1

ER -